Cargando…

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices

OBJECTIVE: Implantable cardioverter defibrillators (ICD), cardiac resynchronisation therapy pacemakers (CRT-P) and the combination therapy (CRT-D) have been shown to reduce all-cause mortality compared with medical therapy alone in patients with heart failure and reduced EF. Our aim was to synthesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woods, B, Hawkins, N, Mealing, S, Sutton, A, Abraham, W T, Beshai, J F, Klein, H, Sculpher, M, Plummer, C J, Cowie, M R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680159/ https://www.ncbi.nlm.nih.gov/pubmed/26269413 http://dx.doi.org/10.1136/heartjnl-2015-307634

Ejemplares similares

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Five-year outcomes following left ventricular assist device implantation in England
por: Bottle, Alex, et al.
Publicado: (2021)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Changes in heart failure management and long-term mortality over 10 years: observational study
por: Bottle, Alex, et al.
Publicado: (2022)

Impact of missed treatment opportunities on outcomes in hospitalised patients with heart failure
por: Walker, Simon, et al.
Publicado: (2017)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis
por: Jenkins, Sam, et al.
Publicado: (2021)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis
por: Yasuda, Masakazu, et al.
Publicado: (2016)

Real-world presentation with heart failure in primary care: do patients selected to follow diagnostic and management guidelines have better outcomes?
por: Bottle, Alex, et al.
Publicado: (2018)

Novel cardiac pacemaker-based human model of periodic breathing to develop real-time, pre-emptive technology for carbon dioxide stabilisation
por: Baruah, Resham, et al.
Publicado: (2014)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Smoking intensity and duration is associated with cardiac structure and function: the ECHOcardiographic Study of Hispanics/Latinos
por: Leigh, J Adam, et al.
Publicado: (2017)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
por: Lampropulos, Julianna F, et al.
Publicado: (2014)

Timing of pacemaker and ICD implantation in LMNA mutation carriers
por: Ollila, Laura Helena, et al.
Publicado: (2021)

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
por: Prior, David L, et al.
Publicado: (2015)

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009)

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)

Update in imaging of cancer therapy-related cardiac toxicity in adults
por: de Baat, Esmée C, et al.
Publicado: (2021)

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Echo-guided left ventricular assist device speed optimisation for exercise maximisation
por: Stapor, Maciej, et al.
Publicado: (2022)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection
por: Giang M, Nhat, et al.
Publicado: (2023)

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
por: Captur, Gabriella, et al.
Publicado: (2018)

Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study
por: Stoevelaar, Rik, et al.
Publicado: (2020)

Impact of nutritional indices on mortality in patients with heart failure
por: Yoshihisa, Akiomi, et al.
Publicado: (2018)

MYOCARDIAL INJURY IS NOT ASSOCIATED WITH MORTALITY IN SEVERE COVID-19
por: O'Brien, Connor G., et al.
Publicado: (2023)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Mortality after admission for heart failure in the UK compared with Japan
por: Nagai, Toshiyuki, et al.
Publicado: (2018)

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease
por: El Sayed, Mohamed, et al.
Publicado: (2021)

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis
por: Schrutka, Lore, et al.
Publicado: (2022)

Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients
por: McCoy, Jodi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hv0k0mlg5j5qjiifedq0oqob3c